DICE THERAPEUTICS INC - COM (DICE)

CUSIP: 23345J104

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
45,489,619
Share change
-6,550,061
Total reported value
$2,113,392,973
Put/Call ratio
230%
Price per share
$46.46
Number of holders
155
Value change
-$47,727,312
Number of buys
113
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 23345J104?
CUSIP 23345J104 identifies DICE - DICE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DICE THERAPEUTICS INC - COM (DICE) as of Q2 2023

As of 30 Jun 2023, DICE THERAPEUTICS INC - COM (DICE) was held by 155 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,489,619 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., FMR LLC, Avoro Capital Advisors LLC, ALPINE ASSOCIATES MANAGEMENT INC., Driehaus Capital Management LLC, VANGUARD GROUP INC, Magnetar Financial LLC, Pentwater Capital Management LP, and UBS OCONNOR LLC. This page lists 155 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.